Tissue Engineering for Wound Care Market Report 2026

The tissue engineering for wound care market size has grown rapidly in recent years. It will grow from $6.93 billion in 2025 to $7.93 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to aging population, diabetes prevalence, burn injuries, hospital wound care programs, advances in biomaterials.

The tissue engineering for wound care market size is expected to see rapid growth in the next few years. It will grow to $13.61 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to growth in chronic wound cases, regenerative medicine adoption, outpatient wound care expansion, innovation in biomaterials, rising healthcare expenditure. Major trends in the forecast period include rising use of bioengineered skin substitutes, growth of chronic wound management solutions, adoption of stem cell-based therapies, expansion of advanced wound care products, focus on faster tissue regeneration.

The growing prevalence of musculoskeletal disorders is expected to drive the expansion of the tissue engineering for wound care market in the coming years. Musculoskeletal disorders involve conditions affecting the muscles, bones, joints, tendons, or ligaments, resulting in pain, stiffness, or restricted movement. The increase in these disorders is largely due to more sedentary lifestyles, as prolonged sitting and reduced physical activity contribute to muscle weakening and joint stress, leading to long-term complications. Tissue engineering for wound care plays a crucial role in musculoskeletal disorders by supporting the regeneration of damaged tissues, restoring both function and structure in areas where natural healing is inadequate. For example, in January 2024, the Office for Health Improvement and Disparities, a UK-based public health agency, reported that 18.4% of individuals aged 16 and over self-reported a long-term musculoskeletal (MSK) condition in 2023, up from 17.6% in 2022. Consequently, the rising prevalence of musculoskeletal disorders is expected to drive the growth of the tissue engineering for wound care market.

Leading companies in the tissue engineering for wound care market are concentrating on developing advanced technological solutions, such as intraoperative 3D printers, to facilitate the rapid prototyping of complex structures. Intraoperative 3D printers are sophisticated devices used during surgeries to create customized implants, models, or tools in real time, enhancing precision and patient-specific treatment. For instance, in September 2024, Tides Medical, a US-based biotechnology company, introduced APLICOR 3D, a personalized wound care intraoperative 3D printer. This technology transforms wound care by using the patient’s own tissue, artificial intelligence, and 3D printing to produce customized skin grafts directly at the treatment site. The procedure addresses each patient’s unique needs while streamlining supply chain logistics, reducing inventory requirements, and minimizing physician workload. After scanning the wound with a specialized tablet to determine exact size, depth, and tissue volume, the provider sends the 3D file to the printer. Once fat is harvested and processed into bio-ink, the 3D printer constructs the graft, allowing effective wound closure in under an hour.

In July 2023, Coloplast A/S, a Denmark-based healthcare technology company, acquired Kerecis Holding ApS for an undisclosed sum. Through this acquisition, Coloplast aims to expand its advanced wound care portfolio by integrating Kerecis’s fish-skin biologic technology and US commercial presence, accelerating growth in the biologics wound care segment. Kerecis Holding ApS, based in Denmark, specializes in providing intact fish-skin-based biologic wound care solutions and related regenerative medicine products.

Major companies operating in the tissue engineering for wound care market are Smith & Nephew plc, ConvaTec Group Plc, MTF Biologics, MiMedx Group Inc., LifeNet Health Inc., Kerecis LLC, Aroa Biosurgery Ltd., Tissue Regenix Group PLC, BioStem Technologies Inc., Organogenesis Holdings Inc., Integra LifeSciences Holdings Corporation, Osiris Therapeutics (Smith & Nephew), Stryker Corporation, Medline Industries LP, Mölnlycke Health Care AB, 3M Health Care, Cardinal Health Inc., Derma Sciences Inc., Acell Inc., Wright Medical Group N.V., Anika Therapeutics Inc., Regen Lab SA, Skye Biologics Inc., Human Regenerative Technologies LLC, StimLabs LLC.

North America was the largest region in the tissue engineering for wound care market in 2025. The regions covered in the tissue engineering for wound care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tissue engineering for wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the tissue engineering for wound care market by increasing the cost of imported biomaterials, scaffolds, and regenerative components used in advanced wound treatment solutions. These impacts are most pronounced in North America and Europe, where reliance on specialized and globally sourced biomaterials is high. Rising tariff related expenses have increased treatment costs and placed pressure on reimbursement and procurement budgets. This has influenced adoption rates of advanced wound care therapies in hospitals and specialty clinics. However, tariffs have encouraged regional biomaterial production, expanded local manufacturing capacity, and strengthened long term supply chain resilience.

The tissue engineering for wound care market research report is one of a series of new reports that provides tissue engineering for wound care market statistics, including tissue engineering for wound care industry global market size, regional shares, competitors with a tissue engineering for wound care market share, detailed tissue engineering for wound care market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering for wound care industry. This tissue engineering for wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Tissue engineering for wound care is a specialized area that aims to enhance the natural repair and regeneration of damaged tissue by combining biological components, such as cells and supportive materials. This method seeks to create an ideal environment that promotes the body’s healing processes by stimulating new tissue formation.

The primary materials used in tissue engineering for wound care include scaffolds, tissue grafts, and others. A scaffold is a three-dimensional framework that provides structural support to cells, allowing them to attach, grow, and differentiate to form new tissue. It is utilized for both chronic and acute wounds and applied in skin regeneration, bone and cartilage repair, soft tissue restoration, and organ regeneration. These materials are used by a variety of end-users, including hospitals, specialty centers and clinics, and ambulatory surgical centers.

The tissue engineering for wound care market consists of revenues earned by entities by providing services such as cell culture and expansion services, biomaterial research and development, and wound healing assessment and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The tissue engineering for wound care market also includes sales of engineered skin substitutes, hydrogel dressings, bioactive wound dressings, and 3D bioprinted tissues. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.